Stroke is a deadly disease without effective
pharmacotherapies, which is due to two major reasons. First, most
therapeutics cannot efficiently penetrate the brain. Second, single agent
pharmacotherapy may be insufficient and effective treatment of
stroke requires targeting multiple complementary targets. Here, we set to develop single component, multifunctional nanoparticles (NPs) for targeted delivery of
glyburide to the brain for
stroke treatment. Methods: To characterize the brain penetrability, we radiolabeled
glyburide, intravenously administered it to
stroke- bearing mice, and determined its accumulation in the brain using positron emission tomography-computed tomography (PET/CT). To identify functional nanomaterials to improve drug delivery to the brain, we developed a chemical extraction approach and tested it for isolation of nanomaterials from E. ulmoides, a medicinal herb. To assess the therapeutic benefits, we synthesized
glyburide-loaded NPs and evaluated them in
stroke- bearing mice. Results: We found that
glyburide has a limited ability to penetrate the ischemic brain. We identified
betulinic acid (BA) capable of forming NPs, which, after
intravenous administration, efficiently penetrate the brain and significantly reduce
ischemia-induced
infarction as an
antioxidant agent. We demonstrated that BA NPs enhance delivery of
glyburide, leading to therapeutic benefits significantly greater than those achieved by either
glyburide or BA NPs. Conclusion: This study suggests a new direction to identify functional nanomaterials and a simple approach to achieving anti-
edema and
antioxidant combination
therapy. The resulting
glyburide- loaded BA NPs may be translated into clinical applications to improve clinical management of
stroke.